M Cemazar
Overview
Explore the profile of M Cemazar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bosnjak M, Znidar K, Sales Conniff A, Jesenko T, Markelc B, Semenova N, et al.
Biomed Pharmacother
. 2022 Jun;
150:113088.
PMID: 35658241
Skin, the largest organ in the body, provides a passive physical barrier against infection and contains elements of the innate and adaptive immune systems. Skin consists of various cells, including...
2.
Komel T, Bosnjak M, Kranjc Brezar S, De Robertis M, Mastrodonato M, Scillitani G, et al.
Bioelectrochemistry
. 2021 Jun;
141:107843.
PMID: 34139572
Gene therapy has become an important approach for treating cancer, and electroporation represents a technology for introducing therapeutic genes into a cell. An example of cancer gene therapy relying on...
3.
Heller L, Bulysheva A, Arpag S, Sales Conniff A, Kohena K, Shi G, et al.
Bioelectrochemistry
. 2021 May;
140:107827.
PMID: 33971375
We developed and characterized a 3D collagen hydrogel model for B16.F10 melanoma tumors. Cells in this 3D environment exhibited lower proliferation than cells in the conventional 2D culture environment. Interestingly,...
4.
Bozic T, Sersa G, Kranjc Brezar S, Cemazar M, Markelc B
Bioelectrochemistry
. 2021 Mar;
140:107795.
PMID: 33789177
The effectiveness of immunotherapy highly correlates with the degree and the type of infiltrated immune cells in the tumor tissue. Treatments based on modifying the immune cell infiltrate of the...
5.
Racnik J, Svara T, Zadravec M, Gombac M, Cemazar M, Sersa G, et al.
N Z Vet J
. 2019 Jan;
67(3):155-158.
PMID: 30626280
No abstract available.
6.
Cemazar M, Sersa G, Frey W, Miklavcic D, Teissie J
Bioelectrochemistry
. 2018 Mar;
122:69-76.
PMID: 29571034
Electric field-induced membrane changes are an important approach in the life sciences. However, the developments in knowledge and translational applications face problems of reproducibility. Indeed, a quick survey of the...
7.
Tozon N, Kramaric P, Kos Kadunc V, Sersa G, Cemazar M
Vet Rec
. 2016 Oct;
179(24):627.
PMID: 27758950
The aim of our study was to evaluate the efficacy of electrochemotherapy (ECT) with cisplatin as a single or adjuvant treatment for sarcoids in equids. Different treatment options with different...
8.
Stimac M, Kamensek U, Cemazar M, Kranjc S, Coer A, Sersa G
Cancer Gene Ther
. 2016 May;
23(7):214-20.
PMID: 27199221
Gene electrotransfer of plasmid encoding shRNA against endoglin exerts antitumor efficacy, predominantly by vascular targeted effect. As vascular targeting therapies can promote radiosensitization, the aim of this study was to...
9.
Cemazar M, Ambrozic Avgustin J, Pavlin D, Sersa G, Poli A, Krhac Levacic A, et al.
Vet Comp Oncol
. 2016 Feb;
15(2):641-654.
PMID: 26840222
Electrochemotherapy combined with peritumoral interleukin-12 (IL-12) gene electrotransfer was used for treatment of mast cell tumours in 18 client-owned dogs. Local tumour control, recurrence rate, as well as safety of...
10.
Bosnjak M, Dolinsek T, Cemazar M, Kranjc S, Blagus T, Markelc B, et al.
Gene Ther
. 2015 Mar;
22(7):578-90.
PMID: 25781650
Gene therapy with Plasmid AMEP (antiangiogenic metargidin peptide) has recently been studied as a potential targeted therapy for melanoma. This plasmid is designed to downregulate α5β1 and αvβ3 integrins. In...